Delivery Order SPE2DR25D2213-SPE2DR26F6DBF
- Not listed
- The Defense Logistics Agency awarded a $30,851.70 delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalation powder (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 3, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalation powder in a 60-dose configuration, with a ceiling value of $13,819.64. This is a firm fixed-price delivery order with an ultimate completion date of December 9, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $2,053.06 to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalation powder (60-count package). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 8, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a $14,351.01 delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 10, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,211.94 to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-count units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of December 11, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a $13,678.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 inhalers (60-count units) on December 10, 2025, with an ultimate completion date of December 11, 2025. This non-set-aside competitive award was issued to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $31,540.49 delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of May 13, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $11,097.32 delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for Trelegy Ellipta 100-62.5-25 inhalers (60-count supply). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 23, 2025, and performance location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units) with a ceiling value of $1,089.41. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement process. The order is set to reach completion by November 4, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a $32,178.86 firm fixed price delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count units) on December 1, 2025, with completion scheduled for December 2, 2025. This non-set-aside award was issued from the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DR25D2213Indefinite Delivery Contract
- SPE2DR25D2213-SPE2DR26F6DBFDelivery Order
The Defense Logistics Agency awarded a $27,876.13 delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalation powder (60-count units). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of December 15, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's pharmaceutical supply portfolio includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. Trelegy Ellipta is a combination inhalation product used for chronic obstructive pulmonary disease management, reflecting AmerisourceBergen's role in supplying essential respiratory therapeutics to the Defense Health Agency and other federal healthcare systems through its comprehensive global pharmaceutical support vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.9k | 12/11/25 |